Join the conversation:
Published by cahoadmin at March 9, 2018
UHN researchers explain the COMPASS trial, which is giving pancreatic cancer patients the ability to have their tumour genomes sequenced very rapidly.
Investments in the health research enterprise have produced widespread and important discoveries that have led to a Healthier, Wealthier and Smarter province. Download our white paper to learn more.